SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 8th, 2018 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJune 8th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 7, 2018, between ReShape Lifesciences Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT RESHAPE LIFESCIENCES INC.ReShape Lifesciences Inc. • June 8th, 2018 • Electromedical & electrotherapeutic apparatus
Company FiledJune 8th, 2018 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on (1) (the “Termination Date”) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).